Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr, who oversees the FDA, has made no secret of his desire to ban ...

The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...

Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide ...

The platform's library of specialised life sciences agents creates an adaptable framework that breaks down silos between data ...

Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

PE-backed specialty pharma company Kelso Pharma, which recently acquired Italian medical device and pharma company Velit ...

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly ...

Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

Pharma has so far been exempted from Trump's tariff blitz, which imposed a flat rate of 10% on imports from 5th April and ...

Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the ...